Sunrise posts loss of $70 million in 2007, rethinks growth plans
Aug 07, 2008
Sunrise Senior Living Inc., a major assisted-living player in the United States, lost more than $70 million last year, and disclosed it would reduce the number of units in its development pipeline.
New drug therapy may ease sleep disruptions due to Alzheimer’s
By
Alicia Lasek
Jul 24, 2019
A new drug has shown promise for regulating sleep in people with mild to moderate Alzheimer’s disease.
Funding for Alzheimer’s research in question
By
McKnight's Staff
Apr 05, 2012
The $80 million President Obama designated to Alzheimer’s research could have more strings attached to it than previously thought, a key senator has said.
Proposal calls for updating diagnostic criteria for Alzheimer’s
By
Kristen Fischer
Jul 18, 2023
The way doctors diagnose Alzheimer’s disease soon could change. A proposal updating existing diagnostic criteria, which was introduced at the Alzheimer’s Association International Conference in Amsterdam,...
New Alzheimer’s drug shows promise in slowing disease
By
John Roszkowski
Sep 29, 2022
In a potentially significant breakthrough in the treatment of Alzheimer’s disease, recently completed clinical trials show a new experimental drug treatment could significantly slow the progression of...
Justice O’Connor addresses full house at Alzheimer’s hearing
May 16, 2008
The Senate Special Committee on Aging played host to two high-profile witnesses this week at a hearing on Alzheimer’s that drew an enormous crowd.
Rules of engagement
By
Julie Williamson
Nov 01, 2013
Personalized programming is a hallmark of effective, enriching dementia care; providing what’s needed becomes easier by knowing habits and preferences.